首页 | 本学科首页   官方微博 | 高级检索  
     


A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial
Authors:Esteban Lopez-de-Sa  Miriam Juarez  Eduardo Armada  José C. Sanchez-Salado  Pedro L. Sanchez  Pablo Loma-Osorio  Alessandro Sionis  Maria C. Monedero  Manuel Martinez-Sellés  Juán C. Martín-Benitez  Albert Ariza  Aitor Uribarri  José M. Garcia-Acuña  Patricia Villa  Pablo J. Perez  Christian Storm  Anne Dee  Jose L. Lopez-Sendon
Affiliation:1.Acute Cardiac Care Unit, Cardiology Department,Hospital Universitario La Paz, IdiPaz. CIBERCV,Madrid,Spain;2.Cardiology Department,Hospital Universitario Gregorio Mara?ón. CIBERCV,Madrid,Spain;3.Cardiology Department,Hospital Universitario de Bellvitge,Barcelona,Spain;4.Cardiology Department,Hospital Universitario de Salamanca,Salamanca,Spain;5.Cardiology Department,Hospital Universitario Josep Trueta,Girona,Spain;6.Intensive Cardiac Care Unit, Cardiology Department,Hospital de Sant Pau. IIB-Sant Pau. CIBERCV, Universitat Autònoma de Barcelona,Barcelona,Spain;7.Universidad Complutense, Avenida Séneca 2, Universidad Europea,Madrid,Spain;8.Intensive Care Department,Hospital Clínico San Carlos,Madrid,Spain;9.Cardiology Department,Complejo Hospitalario Universitario de Santiago. CIBERCV,La Coru?a,Spain;10.Intensive Care Department,Hospital Universitario Principe de Asturias,Madrid,Spain;11.Cardiology Department,Hospital Universitario de Canarias,Santa Cruz de Tenerife,Spain;12.Department of Internal Medicine, Nephrology and Intensive Care,Charité-Universit?tsmedizin,Berlin,Germany;13.Biostatistics Department,ZOLL Medical Corporation,San Jose,USA
Abstract:

Purpose

To obtain initial data on the effect of different levels of targeted temperature management (TTM) in out-of-hospital cardiac arrest (OHCA).

Methods

We designed a multicentre pilot trial with 1:1:1 randomization to either 32 °C (n?=?52), 33 °C (n?=?49) or 34 °C (n?=?49), via endovascular cooling devices during a 24-h period in comatose survivors of witnessed OHCA and initial shockable rhythm. The primary endpoint was the percentage of subjects surviving with good neurologic outcome defined by a modified Rankin Scale (mRS) score of?≤?3, blindly assessed at 90 days.

Results

At baseline, different proportions of patients who had received defibrillation administered by a bystander were assigned to groups of 32 °C (13.5%), 33 °C (34.7%) and 34 °C (28.6%; p?=?0.03). The percentage of patients with an mRS?≤?3 at 90 days (primary endpoint) was 65.3, 65.9 and 65.9% in patients assigned to 32, 33 and 34 °C, respectively, non-significant (NS). The multivariate Cox proportional hazards model identified two variables significantly related to the primary outcome: male gender and defibrillation by a bystander. Among the 43 patients who died before 90 days, 28 died following withdrawal of life-sustaining therapy, as follows: 7/16 (43.8%), 10/13 (76.9%) and 11/14 (78.6%) of patients assigned to 32, 33 and 34 °C, respectively (trend test p?=?0.04). All levels of cooling were well tolerated.

Conclusions

There were no statistically significant differences in neurological outcomes among the different levels of TTM. However, future research should explore the efficacy of TTM at 32 °C.

Clinical trial registration

ClinicalTrials.gov unique identifier: NCT02035839 (http://clinicaltrials.gov).
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号